Home › Trial NCT04235114
Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)
- Trial IDNCT04235114
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorUniversity of Saskatchewan
- Enrollment14
- Start date2020-02-01
- ConditionsLung Cancer · Colorectal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.